4-Quinolone-3-Carboxamide CB2 Ligand |
A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… |
1 mg |
11093-1 |
More Info
|
4-Quinolone-3-Carboxamide CB2 Ligand |
A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… |
10 mg |
11093-10 |
More Info
|
4-Quinolone-3-Carboxamide CB2 Ligand |
A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… |
25 mg |
11093-25 |
More Info
|
4-Quinolone-3-Carboxamide CB2 Ligand |
A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… |
5 mg |
11093-5 |
More Info
|
4-Quinolone-3-Carboxamide Furan CB2 Agonist |
A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… |
1 mg |
11094-1 |
More Info
|
4-Quinolone-3-Carboxamide Furan CB2 Agonist |
A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… |
10 mg |
11094-10 |
More Info
|
4-Quinolone-3-Carboxamide Furan CB2 Agonist |
A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… |
25 mg |
11094-25 |
More Info
|
4-Quinolone-3-Carboxamide Furan CB2 Agonist |
A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… |
5 mg |
11094-5 |
More Info
|
Quin-2 (potassium salt) |
A high-affinity fluorescent calcium indicator (Kd = 115 nM for calcium) th… |
5 mg |
20421-5 |
More Info
|
Quinupristin (mesylate) |
A streptogramin antibiotic that is usually combined with another streptogr… |
1 mg |
19764-1 |
More Info
|
Quinupristin (mesylate) |
A streptogramin antibiotic that is usually combined with another streptogr… |
5 mg |
19764-5 |
More Info
|
Quizartinib |
A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… |
1 mg |
17986-1 |
More Info
|
Quizartinib |
A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… |
10 mg |
17986-10 |
More Info
|
Quizartinib |
A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… |
5 mg |
17986-5 |
More Info
|
Quizartinib |
A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… |
500 µg |
17986-500 |
More Info
|
Q-VD-OPH |
A broad-spectrum caspase inhibitor, blocking caspases-3, -7, -8, -9, -10,… |
1 mg |
15260-1 |
More Info
|
Q-VD-OPH |
A broad-spectrum caspase inhibitor, blocking caspases-3, -7, -8, -9, -10,… |
5 mg |
15260-5 |
More Info
|
QX-77 |
An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… |
10 mg |
29903-10 |
More Info
|
QX-77 |
An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… |
25 mg |
29903-25 |
More Info
|
QX-77 |
An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… |
5 mg |
29903-5 |
More Info
|
QX-77 |
An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… |
50 mg |
29903-50 |
More Info
|
QX-314 (bromide) |
A membrane-impermeant lidocaine derivative that when combined with capsaic… |
100 mg |
10011032-100 |
More Info
|
QX-314 (bromide) |
A membrane-impermeant lidocaine derivative that when combined with capsaic… |
25 mg |
10011032-25 |
More Info
|
QX-314 (bromide) |
A membrane-impermeant lidocaine derivative that when combined with capsaic… |
50 mg |
10011032-50 |
More Info
|
QX-314 (chloride) |
A membrane-impermeant lidocaine derivative that when combined with capsaic… |
50 mg |
18454-50 |
More Info
|
R 1530 |
A multi-kinase inhibitor that targets over 20 kinases, including angiogene… |
1 mg |
15255-1 |
More Info
|
R 1530 |
A multi-kinase inhibitor that targets over 20 kinases, including angiogene… |
10 mg |
15255-10 |
More Info
|
R 1530 |
A multi-kinase inhibitor that targets over 20 kinases, including angiogene… |
25 mg |
15255-25 |
More Info
|
R 1530 |
A multi-kinase inhibitor that targets over 20 kinases, including angiogene… |
5 mg |
15255-5 |
More Info
|
R112 |
A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… |
1 mg |
22929-1 |
More Info
|
R112 |
A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… |
10 mg |
22929-10 |
More Info
|
R112 |
A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… |
25 mg |
22929-25 |
More Info
|
R112 |
A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… |
5 mg |
22929-5 |
More Info
|
R162 |
A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… |
10 mg |
30922-10 |
More Info
|
R162 |
A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… |
25 mg |
30922-25 |
More Info
|
R162 |
A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… |
5 mg |
30922-5 |
More Info
|
R162 |
A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… |
50 mg |
30922-50 |
More Info
|
R-268712 |
An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… |
10 mg |
36810-10 |
More Info
|
R-268712 |
An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… |
100 mg |
36810-100 |
More Info
|
R-268712 |
An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… |
5 mg |
36810-5 |
More Info
|
R-268712 |
An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… |
50 mg |
36810-50 |
More Info
|
R406 |
A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… |
1 mg |
11422-1 |
More Info
|
R406 |
A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… |
10 mg |
11422-10 |
More Info
|
R406 |
A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… |
25 mg |
11422-25 |
More Info
|
R406 |
A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… |
5 mg |
11422-5 |
More Info
|
R428 |
An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… |
1 mg |
21523-1 |
More Info
|
R428 |
An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… |
10 mg |
21523-10 |
More Info
|
R428 |
An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… |
25 mg |
21523-25 |
More Info
|
R547 |
An inhibitor of the cyclin-dependent kinases Cdk1 / cyclin B, Cdk2 / cycli… |
1 mg |
17905-1 |
More Info
|
R547 |
An inhibitor of the cyclin-dependent kinases Cdk1 / cyclin B, Cdk2 / cycli… |
5 mg |
17905-5 |
More Info
|
R-568 |
A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… |
1 mg |
17415-1 |
More Info
|
R-568 |
A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… |
10 mg |
17415-10 |
More Info
|
R-568 |
A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… |
5 mg |
17415-5 |
More Info
|
R-568 |
A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… |
50 mg |
17415-50 |
More Info
|
R-59-022 |
An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… |
1 mg |
16772-1 |
More Info
|
R-59-022 |
An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… |
10 mg |
16772-10 |
More Info
|
R-59-022 |
An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… |
5 mg |
16772-5 |
More Info
|
R-59-022 |
An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… |
50 mg |
16772-50 |
More Info
|
R-59-949 |
A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… |
1 mg |
21221-1 |
More Info
|
R-59-949 |
A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… |
10 mg |
21221-10 |
More Info
|
R-59-949 |
A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… |
25 mg |
21221-25 |
More Info
|
R-59-949 |
A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… |
5 mg |
21221-5 |
More Info
|
R-7050 |
A cell-permeable antagonist of signaling through the TNF-α receptor… |
1 mg |
16870-1 |
More Info
|
R-7050 |
A cell-permeable antagonist of signaling through the TNF-α receptor… |
10 mg |
16870-10 |
More Info
|
R-7050 |
A cell-permeable antagonist of signaling through the TNF-α receptor… |
25 mg |
16870-25 |
More Info
|
R-7050 |
A cell-permeable antagonist of signaling through the TNF-α receptor… |
5 mg |
16870-5 |
More Info
|
R-848 |
An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… |
10 mg |
14806-10 |
More Info
|
R-848 |
An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… |
25 mg |
14806-25 |
More Info
|
R-848 |
An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… |
5 mg |
14806-5 |
More Info
|
R-848 |
An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… |
50 mg |
14806-50 |
More Info
|
R-8507 |
An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… |
1 mg |
22479-1 |
More Info
|
R-8507 |
An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… |
10 mg |
22479-10 |
More Info
|
R-8507 |
An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… |
25 mg |
22479-25 |
More Info
|
R-8507 |
An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… |
5 mg |
22479-5 |
More Info
|
R-6890 |
An analytical reference standard categorized as an opioid; has analgesic e… |
1 mg |
39967-1 |
More Info
|